World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
50
Citations
9163
World Ranking
17630
National Ranking
7233

Overview

Dennis M. Schmatz is affiliated with MSD in the United States, reflecting association with a prominent pharmaceutical company. The professional engagement within this environment suggests involvement in biomedical, pharmaceutical, or related scientific sectors.

No specific recent papers, frequent co-authors, or publication venues have been documented, which limits precise details about the research output or collaborative networks of this scientist.

No records of books published by Dennis M. Schmatz are available, implying that their contributions have likely focused on journals or other scientific communications rather than monographs or edited volumes.

Similarly, there is no available data on the main or subfields of study, which makes it difficult to define the exact domains of expertise or specialization. Likewise, there is no information on principal research topics addressed by the scientist.

No awards have been documented, which indicates either a lack of publicly noted accolades or that such recognitions have not been recorded in the accessible data set.

This profile is based solely on verifiable information from the provided source data without extrapolations beyond the documented academic and professional affiliations.

Best Publications

  • Platensimycin is a selective FabF inhibitor with potent antibiotic properties

    Jun Wang;Stephen M. Soisson;Katherine Young;Wesley Shoop;Wesley Shoop

  • Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase

    Sandra J. Darkin-Rattray;Anne M. Gurnett;Robert W. Myers;Paula M. Dulski

  • The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro

    J. C. Bowman;P. Scott Hicks;M. B. Kurtz;H. Rosen

  • Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

    J. C. Bowman;G. K. Abruzzo;J. W. Anderson;A. M. Flattery

  • Discovery of FabH/FabF Inhibitors from Natural Products

    Katherine Young;Hiranthi Jayasuriya;John G. Ondeyka;Kithsiri Herath

  • Identification of two novel Drosophila melanogaster histamine-gated chloride channel subunits expressed in the eye.

    Yingcong Zheng;Birgit Hirschberg;Jeffrey Yuan;Alice P. Wang

  • Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin

    Nanci S. Kane;Birgit Hirschberg;Su Qian;David Hunt

  • Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis.

    Michael C. Justice;Ming-Jo Hsu;Bruno Tse;Theresa Ku

  • Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

    D M Schmatz;M A Romancheck;L A Pittarelli;R E Schwartz

  • Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target.

    Anne M. Gurnett;Paul A. Liberator;Paula M. Dulski;Scott P. Salowe

  • Purification of Eimeria Sporozoites by DE-52 Anion Exchange Chromatography

    Dennis M. Schmatz;Mark St. J. Crane;P. Keith Murray

  • Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii.

    M A Powles;P Liberator;J Anderson;Y Karkhanis

  • Structure and Chemistry of Apicidins, a Class of Novel Cyclic Tetrapeptides without a Terminal α-Keto Epoxide as Inhibitors of Histone Deacetylase with Potent Antiprotozoal Activities

    Sheo B. Singh;Deborah L. Zink;Jerrold M. Liesch;Ralph T. Mosley

  • Apicidins: Novel cyclic tetrapeptides as coccidiostats and antimalarial agents from Fusarium pallidoroseum

    Sheo B. Singh;Deborah L. Zink;Jon D. Polishook;Anne W. Dombrowski

  • Determination of selectivity and efficacy of fatty acid synthesis inhibitors.

    Srinivas Kodali;Andrew Galgoci;Katherine Young;Ronald Painter

  • SAR of 3,4-dihydropyrido[3,2-d]pyrimidone p38 inhibitors.

    Luping Liu;John E. Stelmach;Swaminathan R. Natarajan;Meng-Hsin Chen

  • Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds

    Tesfaye Biftu;Steven L. Colletti;Charles J. Mcintyre;Dennis M. Schmatz

  • Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents

    Tesfaye Biftu;Dennis Feng;Michael Fisher;Gui-Bai Liang

  • In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.

    K Bartizal;G Abruzzo;C Trainor;D Krupa

  • Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase.

    John E. Stelmach;Luping Liu;Sangita B. Patel;James V. Pivnichny

Frequent Co-Authors

Matthew J. Wyvratt
Matthew J. Wyvratt Medicines for Malaria Venture
Michael H. Fisher
Michael H. Fisher MSD (United States)
Robert E. Schwartz
Robert E. Schwartz Cornell University
Sheo B. Singh
Sheo B. Singh MSD (United States)
Gerald F. Bills
Gerald F. Bills The University of Texas Health Science Center at Houston
Deborah L. Zink
Deborah L. Zink Weizenbaum-Institut
Fernando Pelaez
Fernando Pelaez Spanish National Cancer Research Centre
Giovanna Scapin
Giovanna Scapin MSD (United States)
Jonathan A. Ellman
Jonathan A. Ellman Yale University
Richard A. Berger
Richard A. Berger Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Dennis M. Schmatz

Trending Scientists